Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 328
Filtrar
1.
Ocul Immunol Inflamm ; 31(10): 1965-1970, 2023 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-37983819

RESUMEN

Sarcoidosis is a multi-system granulomatous disease that often presents with uveitis. Although sarcoidosis and sarcoid uveitis typically occur in adulthood, children also may be affected. There are two distinct clinical presentations of the pediatric disease, associated with younger and older age groups, and having different causations. "Early-onset sarcoidosis", beginning at age 5 years or less, is an autosomal dominant genetic disease, caused by a mutation in the NOD2 gene. It is also known as sporadic Blau syndrome or Jabs syndrome. "Adult-type sarcoidosis", usually beginning between the ages of 8 and 15 years, is believed to represent an excessive response to an environmental antigen. There is limited literature on the management of pediatric sarcoidosis, and treatment follows an approach applied to other forms of pediatric non-infectious uveitis. When systemic immunomodulatory therapy is indicated, methotrexate and/or adalimumab are often employed. The condition may persist into adulthood, and thus long-term follow-up is indicated.


Asunto(s)
Artritis , Sarcoidosis , Sinovitis , Uveítis , Adulto , Humanos , Niño , Anciano , Adolescente , Uveítis/diagnóstico , Uveítis/tratamiento farmacológico , Uveítis/etiología , Sarcoidosis/diagnóstico , Sarcoidosis/complicaciones , Artritis/genética , Sinovitis/complicaciones
2.
Vet Comp Orthop Traumatol ; 36(6): 294-301, 2023 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-37487535

RESUMEN

OBJECTIVE: The aim of this study was to examine a method for measuring femoral trochlear morphology in dogs using ultrasonography, and survey femoral trochlear morphology in skeletally normal dogs. STUDY DESIGN: To examine the validity of ultrasonography, three raters measured the sulcus angle (SA; the angle between the medial and lateral facets) five times in five skeletally normal dogs. Intra- and interrater reliabilities were then calculated. We also calculated the correlation coefficient between SAs measured using ultrasonography and computed tomography (CT) or magnetic resonance imaging (MRI). Then, we surveyed the femoral trochlear morphology in skeletally normal dogs using ultrasonography. RESULTS: The intra- and interrater reliability for SAs measured using ultrasonography was good, and the correlation coefficient between SAs measured using ultrasonography and CT, or MRI, was strong. In skeletally normal dogs, the SAs for osseous contours decreased until 6 months of age. However, the SAs for cartilaginous contours did not change during the growth period. CONCLUSION: The ultrasonographic measurement method is reliable for the evaluation of femoral trochlear morphology in dogs. The contour of the articular cartilage surface of the femoral trochlea is already determined early in life, and ossification of the articular cartilage of the femoral trochlea proceeds until 6 months of age. The results of this study will provide crucial information for the evaluation of femoral trochlear morphology in dogs.


Asunto(s)
Cartílago Articular , Fémur , Perros , Animales , Reproducibilidad de los Resultados , Fémur/diagnóstico por imagen , Imagen por Resonancia Magnética/métodos , Ultrasonografía
3.
Indian J Ophthalmol ; 71(6): 2587-2591, 2023 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-37322685

RESUMEN

Vogt-Koyanagi-Harada (VKH) disease, a bilateral granulomatous panuveitis associated with multisystem involvement, is a T-cell-mediated autoimmune disorder in which cytotoxic T-cell target melanocytes in genetically susceptible individuals. Recently, there has been an increase in literature on the new onset of uveitis and reactivation of previously diagnosed cases of uveitis following Covid-19 vaccinations. It has been postulated that Covid-19 vaccines can lead to an immunomodulatory change resulting in an autoimmune phenomenon in the recipients. VKH following COVID-19 infection was reported in four patients and a total of 46 patients developing VKH or VKH-like disease following COVID-19 vaccinations. There are reports of four patients who had been recovering or recovered from VKH after receiving the first dosage of the vaccine and developed worsening of ocular inflammation after receiving the second dose of the vaccine.


Asunto(s)
COVID-19 , Panuveítis , Uveítis , Síndrome Uveomeningoencefálico , Humanos , Síndrome Uveomeningoencefálico/complicaciones , Síndrome Uveomeningoencefálico/diagnóstico , Vacunas contra la COVID-19 , Panuveítis/diagnóstico
4.
Ocul Immunol Inflamm ; 31(7): 1416-1424, 2023 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-36803501

RESUMEN

Human T-cell leukemia virus type 1 (HTLV-1) is a human retrovirus that causes T-cell malignant diseases (adult T-cell leukemia/lymphoma) and HTLV-1-related non-malignant inflammatory diseases, such as HTLV-1 uveitis. Although the symptoms and signs of HTLV-1 uveitis are nonspecific, intermediate uveitis with various degrees of vitreous opacity is the most common clinical presentation. It can occur in one or both eyes and its onset is acute or subacute. Intraocular inflammation can be managed with topical and/or systemic corticosteroids; however, recurrence of uveitis is common. The visual prognosis is generally favorable, but a certain proportion of patients have a poor visual prognosis. Systemic complications of patients with HTLV-1 uveitis include Graves' disease and HTLV-1-associated myelopathy/tropical spastic paraparesis. This review describes the clinical characteristics, diagnosis, ocular manifestations, management, and immunopathogenic mechanisms of HTLV-1 uveitis.


Asunto(s)
Enfermedad de Graves , Infecciones por HTLV-I , Virus Linfotrópico T Tipo 1 Humano , Leucemia de Células T , Leucemia-Linfoma de Células T del Adulto , Uveítis , Adulto , Humanos , Uveítis/diagnóstico , Ojo , Enfermedad de Graves/complicaciones , Trastornos de la Visión , Leucemia de Células T/complicaciones , Leucemia-Linfoma de Células T del Adulto/complicaciones , Leucemia-Linfoma de Células T del Adulto/diagnóstico
5.
Ocul Immunol Inflamm ; 31(7): 1405-1415, 2023 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-36698066

RESUMEN

Laboratory investigations can play a significant role in the diagnosis and decision-making of infectious uveitis. Though direct demonstration of the infective organism remains the gold standard of diagnosis, it is not always possible with ocular tissues. Recent advancements in molecular techniques have made it possible to overcome these limitations and to identify the genomic DNA of pathogens associated with infectious uveitis. Techniques such as next-generation sequencing can analyze all DNA-based lifeforms, regardless of whether they are bacteria, fungi, viruses, or parasites and have been used in the laboratory diagnosis of intraocular inflammation. On the other hand, serological tests, though they dominate the diagnostic landscape of various infectious etiologies in uveitis in routine clinical practice, have varied specificities and sensitivities in different infectious uveitis. In this review, we focus on various methods of laboratory diagnosis of infectious uveitis and discuss the recent advances in molecular diagnosis and their role in various infectious clinical entities.


Asunto(s)
Infecciones Bacterianas del Ojo , Uveítis , Humanos , Uveítis/diagnóstico , ADN
6.
BMJ Open ; 12(7): e060701, 2022 07 28.
Artículo en Inglés | MEDLINE | ID: mdl-35902200

RESUMEN

INTRODUCTION: Vitreoretinal lymphoma is a rare ocular cancer with high morbidity and mortality despite treatment. Diagnosis by cytopathology is often delayed, and various molecular and image-based investigations have been developed. Diverse treatments are used, but there is a limited medical evidence to differentiate their effectiveness. We designed an international registry that would collect diagnostic, treatment and outcomes data, to establish new evidence for the management of this cancer. METHODS AND ANALYSIS: The International Vitreoretinal B-Cell Lymphoma Registry will accrue data retrospectively for individuals aged 18 years or older, diagnosed with new or recurrent vitreoretinal B-cell lymphoma on or after 1 January 2020. A steering committee of subspecialised ophthalmologists identified 20 key clinical data items that describe patient demographics, tissue involvements, diagnostic testing, ocular and systemic treatments and treatment complications, and visual acuity and survival outcomes. Customised software was designed to permit collection of these data across a single baseline and multiple follow-up forms. The platform collects data without identifiers and at 3 month reporting intervals. Outcomes of the project will include: (1) descriptions of clinical presentations, and diagnostic and therapeutic preferences; (2) associations between clinical presentations, and diagnostics and treatments, and between diagnostics and treatments (assessed by ORs with 95% CIs); and (3) estimations of rates of vision loss, and progression-free and overall survival (assessed by Kaplan-Meier estimates). ETHICS AND DISSEMINATION: The registry has received Australia-wide approval by a national human research ethics committee. Sites located outside Australia are required to seek local human research ethics review. Results generated through the registry will be disseminated primarily by peer-reviewed publications that are expected to inform clinical practice, as well as educational materials.


Asunto(s)
Neoplasias del Ojo , Linfoma de Células B , Neoplasias de la Retina , Humanos , Recurrencia Local de Neoplasia/patología , Sistema de Registros , Neoplasias de la Retina/diagnóstico , Neoplasias de la Retina/epidemiología , Neoplasias de la Retina/terapia , Estudios Retrospectivos , Cuerpo Vítreo/patología
7.
Vet Comp Orthop Traumatol ; 35(5): 314-320, 2022 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-35760367

RESUMEN

Trochleoplasty is often performed in dogs with medial patellar luxation (MPL); however, the current guidelines on when to perform a trochleoplasty in dogs are vague. The sulcus angle (SA) is used to assess the femoral trochlear morphology in humans. The aim of this study is to describe a method to measure the SA and other parameters of trochlea morphology in dogs using computed tomography. First, we searched for a suitable measuring location for the SA. Transverse images of the femurs were obtained as perpendicular planes to the tangent of the femoral trochlea which was 0 to 60 degrees (every 5 degrees) to the anatomical axis of the femur. The deepest point of the femoral trochlea was found in the transverse images perpendicular to the tangent of the femoral trochlea which was at 15 degrees to the anatomical axis of the femur. The SA and the other parameters of femoral trochlea morphology were measured at the deepest point of the femoral trochlea. The SA of the stifle joints with grade 3 and 4 MPL was significantly higher than the SA of stifle joints not affected by MPL. There was no significant difference in the SA between dogs affected by grade 1 and 2 MPL and dogs not affected by MPL. Further studies are needed to establish whether the SA can be used as selection criteria for trochleoplasty.


Asunto(s)
Enfermedades de los Perros , Luxación de la Rótula , Humanos , Perros , Animales , Luxación de la Rótula/diagnóstico por imagen , Luxación de la Rótula/veterinaria , Luxación de la Rótula/cirugía , Rodilla de Cuadrúpedos/cirugía , Fémur/diagnóstico por imagen , Fémur/cirugía , Tomografía Computarizada por Rayos X/veterinaria , Rótula/cirugía , Enfermedades de los Perros/cirugía
8.
Prog Retin Eye Res ; 90: 101053, 2022 09.
Artículo en Inglés | MEDLINE | ID: mdl-35210172

RESUMEN

Vitreoretinal lymphoma (VRL) is a subtype of diffuse large B-cell lymphoma and is sight- and life-threatening in the vast majority of patients. Lymphoma cells infiltrate the vitreous body and/or subretinal space and exhibit clinical signs of vitreous opacities and creamy white subretinal lesions. Although the intraocular signs can serve as clues to suspect VRL, they are nonspecific and may be misdiagnosed as uveitis. Histopathological evidence of malignant cells on vitreous biopsy, for instance, is the gold standard for diagnosis of VRL; however, cytological examination of the vitreous often results in a low success rate owing to the small quantity and poor quality of tissues and cells in the sample. Recent advancements in immunological, molecular, and gene analyses using intraocular samples have made it possible to accurately diagnose VRL. As for the management of VRL, local treatments with irradiation and/or intravitreal injections of anti-tumor agents (methotrexate or rituximab) are effective in suppressing intraocular VRL lesions. However, the effect of systemic chemotherapy, with or without brain irradiation, on preventing central nervous system involvements remains controversial. In this review article, we discuss the following concepts based on previous literature and our unpublished results: current ocular imaging examinations such as optical coherence tomography and fundus autofluorescence; immunological, molecular, and gene expression characterization of intraocular biopsies with special attention to flow cytometry; immunoglobulin gene rearrangement assays that use the polymerase chain reaction test; cytokine assays; gene mutations (MYD88, CD79B); and current local and systemic treatments of VRL.


Asunto(s)
Antineoplásicos , Linfoma , Neoplasias de la Retina , Antineoplásicos/uso terapéutico , Humanos , Linfoma/diagnóstico , Linfoma/terapia , Mutación , Neoplasias de la Retina/tratamiento farmacológico , Neoplasias de la Retina/terapia , Cuerpo Vítreo/patología
9.
BMC Ophthalmol ; 22(1): 48, 2022 Feb 02.
Artículo en Inglés | MEDLINE | ID: mdl-35105322

RESUMEN

BACKGROUND: Human herpesvirus 6B (HHV-6B) is known to cause exanthema subitem and has been detected in various ocular diseases, including keratitis, uveitis, optic neuritis, and endophthalmitis; however, the long-term outcome after the reactivation of HHV-6B has not been well-addressed. Sugita et al. previously reported the concomitant presence of HHV-6B with herpes simplex virus-1 (HSV-1) in the aqueous fluid at the onset of corneal endotheliitis. We focused on the same patient with corneal endotheliitis, in whom both HSV-1 and HHV-6B sequences were observed, and reported the clinical course and long-term outcomes. CASE PRESENTATION: A 64-year-old woman was referred to our center for visual disturbances in the left eye. Her best-corrected visual acuity in the left eye was 0.5 and the left intraocular pressure was elevated to 33 mmHg. Mid-sized keratic precipitates and 2+ cells were observed in the anterior chamber with corneal endothelial edema and reduction of the corneal endothelial cell density to 1828 cells/mm2. The patient was diagnosed with corneal endotheliitis with increased intraocular pressure. Polymerase chain reaction analysis revealed the concomitant presence of both HSV-1 and HHV-6B sequences in the left aqueous fluid. After treatment with oral valacyclovir and topical betamethasone, her intraocular inflammation gradually improved and has not recurred at 12 years after corneal endotheliitis onset although corneal opacity remained. CONCLUSIONS: Reactivation of HHV-6B infection might be associated with HSV-1 corneal endotheliitis; however, no serious late sequelae occurred after appropriate treatment for HSV-1 infection in this immunocompetent host.


Asunto(s)
Edema Corneal , Herpesvirus Humano 1 , Herpesvirus Humano 6 , Queratitis , Endotelio Corneal , Femenino , Herpesvirus Humano 1/genética , Herpesvirus Humano 6/genética , Humanos , Persona de Mediana Edad
10.
Ocul Immunol Inflamm ; 30(1): 48-53, 2022 Jan 02.
Artículo en Inglés | MEDLINE | ID: mdl-32945715

RESUMEN

Purpose: To identify the clinical characteristics of acute retinal necrosis (ARN) and clarify factors associated with poor visual prognosis.Methods: a nationwide multi-center retrospective chart review study was performed in Japan using data from the medical records of 149 consecutive ARN patients. Demographics, ocular signs, virologic testing of intraocular fluids, and treatment were examined. Factors associated with poor visual prognosis were investigated by regression analysis.Results: At initial presentation, anterior chamber cells or mutton-fat keratic precipitates (97%), unilaterality (93%), and yellow-white retinal lesions (86%) were recognized. In the clinical course, rapid circumferential expansion of retinal lesions (39%), development of retinal break or retinal detachment (55%), and optic atrophy (43%) were recorded. Four variables were identified as associated with poor visual prognosis.Conclusions: The present study identified clinical characteristics and factors associated with poor visual prognosis of ARN.


Asunto(s)
Desprendimiento de Retina , Síndrome de Necrosis Retiniana Aguda , Humanos , Pronóstico , Desprendimiento de Retina/diagnóstico , Síndrome de Necrosis Retiniana Aguda/diagnóstico , Síndrome de Necrosis Retiniana Aguda/tratamiento farmacológico , Estudios Retrospectivos , Agudeza Visual
11.
Jpn J Ophthalmol ; 66(2): 119-129, 2022 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-34689288

RESUMEN

PURPOSE: To compare the efficacy and safety of a combination therapy of prednisolone and cyclosporine and corticosteroid pulse therapy in Vogt-Koyanagi-Harada (VKH) disease. STUDY DESIGN: A prospective, multicenter, randomized, non-inferiority trial. METHODS: Patients of new-onset acute VKH disease at 11 centers in Japan between 2014 and 2018 were randomized to a combination (oral prednisolone 60 mg daily with gradual taper-off to 35 mg/day and cyclosporine 3 mg/kg/day) and corticosteroid (methylprednisolone 1000 mg for 3 days followed by oral prednisolone) groups, and were followed for 1 year. RESULTS: Thirty-four were assigned to the combination and thirty-six patients to the corticosteroid group. Recurrence/worsening risk was 0.15 (95% confidence-interval [CI] 0.03-0.27) in the combination group and 0.25 (95% CI 0.11-0.39) in the corticosteroid group, with a risk difference of - 0.10 (90% CI - 0.27 to 0.06), demonstrating non-inferiority of the combination group with a non-inferiority margin of 0.20 (P = 0.0013). Serious adverse events occurred in three patients (two with hyponatremia and one with severe headaches) in the combination group and none in the corticosteroid group. Sunset glow fundus grades and cataract rates at 1 year were 0.57 (95% CI 0.42-71) and 4.3% in the combination group and 0.91 (95% CI 0.78-1.04) and 34.0% in the corticosteroid group, respectively. CONCLUSIONS: Combination therapy was noninferior to corticosteroid therapy with respect to recurrence/worsening risk. Notably, the recurrence/worsening risk, sunset glow fundus grade, and cataract rate were lower in the combination group than in the corticosteroid group.


Asunto(s)
Ciclosporina/uso terapéutico , Metilprednisolona/uso terapéutico , Síndrome Uveomeningoencefálico , Humanos , Estudios Prospectivos , Síndrome Uveomeningoencefálico/diagnóstico , Síndrome Uveomeningoencefálico/tratamiento farmacológico
12.
J Vet Med Sci ; 84(1): 31-35, 2022 Jan 07.
Artículo en Inglés | MEDLINE | ID: mdl-34866093

RESUMEN

A 5-day-old male crossbred beef calf presented with a well-coordinated bilateral hopping gait of the hind limbs. Postmortem CT showed a poorly defined oval-shaped region at the L3-L4 spinal segments, which had high signal intensity on T2 weighted postmortem MRI images. On pathological examination, we identified a large cystic cavity filled with a large amount of cerebrospinal fluid on the cut surface of the spinal region. Histopathological examination revealed that the spinal cord parenchyma was compressed by the cystic structure, and the cystic cavity was lined with a thin layer of discrete ependymal cells, indicating syringohydromyelia. This is the first reported case of a Holstein-Friesian × Japanese Black crossbred calf with solitary syringohydromyelia. Our findings suggest that myelodysplasia with cystic cavities can be suspected by CT, without the need for MRI.


Asunto(s)
Enfermedades de los Bovinos , Médula Espinal , Animales , Autopsia/veterinaria , Bovinos , Miembro Posterior , Imagen por Resonancia Magnética , Masculino
13.
Clin Exp Ophthalmol ; 49(9): 997-999, 2021 12.
Artículo en Inglés | MEDLINE | ID: mdl-34741497
14.
Cancers (Basel) ; 13(16)2021 Aug 04.
Artículo en Inglés | MEDLINE | ID: mdl-34439078

RESUMEN

Vitreoretinal lymphoma (VRL) is a rare variant of primary central nervous system lymphoma (PCNSL), mostly of diffuse large B cell lymphoma, which affects the retina and/or the vitreous with or without optic nerve involvement. The disease course is aggressive. Up to 90% of the patients develop central nervous system lymphoma within one year. The diagnosis of VRL is challenging due to nonspecific chronic and relapsing uveitis and is made by anterior chamber tab or vitreous aspirate biopsy. There is no established treatment protocol for VRL patients with bilateral involvement without CNS involvement. There are suggestions to use only intravitreal chemotherapy with methotrexate and/or rituximab. Alternatively, systemic high-dose MTX treatment or external beam radiotherapy is used. Further studies are needed to prove and confirm the prophylactic systemic therapy in preventing CNS involvement in limited VRL.

15.
Ocul Immunol Inflamm ; 29(3): 507-520, 2021 Apr 03.
Artículo en Inglés | MEDLINE | ID: mdl-34009095

RESUMEN

PURPOSE: To provide recommendations for diagnosis of vitreoretinal lymphoma (VRL). METHODS: Literature was reviewed for reports supporting the diagnosis of VRL. A questionnaire (Delphi 1 round) was distributed to 28 participants. In the second round (Delphi 2), items of the questionnaire not reaching consensus (75% agreement) were discussed to finalize the recommendations. RESULTS: Presenting symptoms include floaters and painless loss of vision, vitreous cells organized into sheets or clumps. Retinal lesions are usually multifocal creamy/white in the outer retina. Other findings include retinal lesions with "leopard-skin" appearance and retinal pigment epithelium atrophy. Severe vitreous infiltration without macular edema is the most likely presentation. Diagnostic vitrectomy should be performed. Systemic corticosteroid should be discontinued at least 2 weeks before surgery. An interleukin (IL)-10:IL-6 ratio > 1, positive mutation for the myeloid differentiation primary response 88 gene and monoclonality are indicators of VRL. Multi-modal imaging (optical coherence tomography, fundus autofluorescence) are recommended. CONCLUSIONS: A consensus meeting allowed the establishment of recommendations important for the diagnosis of VRL.


Asunto(s)
Linfoma Intraocular/diagnóstico , Linfoma de Células B Grandes Difuso/diagnóstico , Neoplasias de la Retina/diagnóstico , Cuerpo Vítreo/patología , Biomarcadores de Tumor/metabolismo , Análisis Mutacional de ADN , Técnica Delphi , Humanos , Interleucina-10/metabolismo , Interleucina-6/metabolismo , Linfoma Intraocular/genética , Linfoma Intraocular/metabolismo , Linfoma de Células B Grandes Difuso/genética , Linfoma de Células B Grandes Difuso/metabolismo , Mutación Missense , Factor 88 de Diferenciación Mieloide/genética , Neoplasias de la Retina/genética , Neoplasias de la Retina/metabolismo , Estudios Retrospectivos , Encuestas y Cuestionarios , Cuerpo Vítreo/metabolismo
16.
Am J Ophthalmol ; 227: 191-200, 2021 07.
Artículo en Inglés | MEDLINE | ID: mdl-33773985

RESUMEN

PURPOSE: To determine distinguishing features of the clinical characteristics of anterior uveitis (AU) caused by herpes simplex virus (HSV), varicella-zoster virus (VZV), and cytomegalovirus (CMV). DESIGN: Retrospective, multicenter case series. METHODS: Consecutive patients with herpetic AU examined at 11 tertiary centers in Japan between January 2012 and December 2017 and who were followed for ≥3 months were evaluated. Diagnosis was made by polymerase chain reaction (PCR) for HSV, VZV, or CMV in the aqueous humor, or classical signs of herpes zoster ophthalmicus. RESULTS: This study enrolled 259 herpetic AU patients, including PCR-proven HSV-AU (30 patients), VZV-AU (50), and CMV-AU (147), and herpes zoster ophthalmicus (32). All HSV-AU and VZV-AU patients were unilateral, while 3% of CMV-AU patients were bilateral. Most HSV-AU and VZV-AU patients were sudden onset with an acute clinical course, while CMV-AU had a more insidious onset and chronic course. There were no significant differences for all surveyed symptoms, signs, and complications between HSV-AU and VZV-AU. However, significant differences were detected for many items between CMV-AU and the other two herpetic AU types. Ocular hyperemia and pain, blurring of vision, ciliary injection, medium-to-large keratic precipitates (KPs), cells and flare in the anterior chamber, and posterior synechia significantly more often occurred in HSV-AU and VZV-AU vs CMV-AU. In contrast, small KPs, coin-shaped KPs, diffuse iris atrophy, elevated intraocular pressure, and glaucoma surgery were significantly more frequent in CMV-AU vs HSV-AU and VZV-AU. CONCLUSION: This multicenter, retrospective study identified distinguishing features of HSV-AU, VZV-AU, and CMV-AU.


Asunto(s)
Infecciones por Citomegalovirus/diagnóstico , Infecciones Virales del Ojo/diagnóstico , Herpes Simple/diagnóstico , Herpes Zóster Oftálmico/diagnóstico , Uveítis Anterior/diagnóstico , Adulto , Anciano , Anciano de 80 o más Años , Antivirales/uso terapéutico , Humor Acuoso/virología , Citomegalovirus/genética , Citomegalovirus/aislamiento & purificación , Infecciones por Citomegalovirus/tratamiento farmacológico , Infecciones por Citomegalovirus/fisiopatología , Infecciones por Citomegalovirus/virología , Infecciones Virales del Ojo/tratamiento farmacológico , Infecciones Virales del Ojo/fisiopatología , Infecciones Virales del Ojo/virología , Femenino , Herpes Simple/tratamiento farmacológico , Herpes Simple/fisiopatología , Herpes Simple/virología , Herpes Zóster Oftálmico/tratamiento farmacológico , Herpes Zóster Oftálmico/fisiopatología , Herpes Zóster Oftálmico/virología , Herpesvirus Humano 3/genética , Herpesvirus Humano 3/aislamiento & purificación , Humanos , Presión Intraocular/fisiología , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Estudios Retrospectivos , Simplexvirus/genética , Simplexvirus/aislamiento & purificación , Uveítis Anterior/tratamiento farmacológico , Uveítis Anterior/fisiopatología , Uveítis Anterior/virología , Agudeza Visual/fisiología , Adulto Joven
17.
Ophthalmology ; 128(5): 729-739, 2021 05.
Artículo en Inglés | MEDLINE | ID: mdl-32987046

RESUMEN

PURPOSE: Current polymerase chain reaction (PCR) methods for the diagnosis of infections are time consuming and require large sample volume and skilled technicians. We developed a novel, easy-to-use, and rapid (processing time, 1 minute; total time, 33 minutes) multiplex real-time PCR test (Direct Strip PCR) that did not require DNA extraction to detect 9 pathogens that could cause uveitis in 20-µl samples. DESIGN: Multicenter prospective evaluation of a diagnostic PCR test. PARTICIPANTS: A total of 511 participants (patients with infectious uveitis and controls) were examined at 18 institutes worldwide. METHODS: After validation, intraocular fluid samples were subjected to etiologic or exclusive diagnosis, including intraoperative rapid diagnosis. MAIN OUTCOME MEASURES: The concordance and correlations between Direct Strip PCR and quantitative PCR (qPCR) results. RESULTS: Direct Strip PCR exhibited rapid detection, good repeatability and specificity, long storage stability, and detection ability equal to that of qPCR. It also showed low interinstitutional variability compared with qPCR, even when PCR beginners used various real-time PCR machines. The Direct Strip PCR for 9 pathogens exhibited high concordance against the qPCR (positive concordance rate, 98.8%-100%; negative concordance rate, 99.8%-100%; κ coefficient, 0.969-1.000; P < 0.001-0.031). Additionally, results obtained using Direct Strip PCR and qPCR were highly correlated (ρ = 0.748; P < 0.001). This assay was used for rapid intraoperative diagnosis. CONCLUSIONS: The Direct Strip PCR test may improve the prognosis of various infectious diseases because it facilitates rapid etiologic evaluation at the first hospital visit and can be used for intraoperative diagnosis.


Asunto(s)
Infecciones Parasitarias del Ojo/diagnóstico , Infecciones Virales del Ojo/diagnóstico , Reacción en Cadena de la Polimerasa Multiplex/métodos , Enfermedades Parasitarias/diagnóstico , Uveítis/parasitología , Uveítis/virología , Virosis/diagnóstico , Anciano , Anciano de 80 o más Años , Animales , Humor Acuoso/parasitología , Humor Acuoso/virología , Cartilla de ADN/química , ADN Protozoario/aislamiento & purificación , ADN Viral/aislamiento & purificación , Técnicas de Diagnóstico Oftalmológico , Infecciones Parasitarias del Ojo/parasitología , Infecciones Virales del Ojo/virología , Femenino , Humanos , Periodo Intraoperatorio , Masculino , Persona de Mediana Edad , Parásitos/genética , Parásitos/aislamiento & purificación , Enfermedades Parasitarias/parasitología , Estudios Prospectivos , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Virosis/virología , Virus/genética , Virus/aislamiento & purificación , Cuerpo Vítreo/parasitología , Cuerpo Vítreo/virología
18.
Br J Ophthalmol ; 105(11): 1515-1519, 2021 11.
Artículo en Inglés | MEDLINE | ID: mdl-32933934

RESUMEN

AIMS: To establish expert recommendations for the management of ocular sarcoidosis (OS). METHODS: A question-based survey on the management of OS was circulated to international uveitis experts (members of the International Uveitis Study Group and the International Ocular Inflammation Society) electronically. Subsequently, a consensus workshop was conducted at the 7th International Workshop on Ocular Sarcoidosis (IWOS) in June 2019 in Sapporo, Japan as part of the Global Ocular Inflammation Workshops. Statements on the management of OS that were supported by a two-thirds majority of 10 international panel members of the workshop, after discussion and voting, were taken as consensus agreement. RESULTS: A total of 98 participants from 29 countries responded to the questionnaire survey. The subsequent consensus workshop established recommendations for the management of OS in five sections. The first section concerned evaluation and monitoring of inflammation. The second, third and fourth sections described ocular manifestations that were indications for treatment, and the management of anterior uveitis, intermediate uveitis and posterior uveitis. In the fifth section, the use of systemic corticosteroids and systemic immunosuppressive drugs were detailed. CONCLUSIONS: Recommendations for management of OS were formulated through an IWOS consensus workshop.


Asunto(s)
Endoftalmitis , Sarcoidosis , Uveítis , Conferencias de Consenso como Asunto , Endoftalmitis/diagnóstico , Endoftalmitis/terapia , Guías como Asunto , Humanos , Inflamación , Sarcoidosis/diagnóstico , Sarcoidosis/terapia , Sociedades Médicas , Uveítis/diagnóstico , Uveítis/terapia
19.
Ocul Immunol Inflamm ; 29(7-8): 1501-1506, 2021 Nov 17.
Artículo en Inglés | MEDLINE | ID: mdl-32469694

RESUMEN

Purpose: To validate the revised criteria of the International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis (OS).Methods: A retrospective chart review study was performed on 323 patients including 51 patients with biopsy-proven sarcoidosis and 272 patients with other uveitis entities. Data on intraocular signs and systemic investigations were collected, and sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and the Youden index were calculated.Results: All intraocular signs and most systemic investigations showed high diagnostic parameters. Sensitivity, specificity, PPV, and NPV of the revised IWOS criteria were 1.000, 0.930, 0.728, and 1.000, respectively. Presumed or probable OS showed lower sensitivity and higher specificity when compared with the best Youden index.Conclusion: The revised IWOS criteria are useful in Japanese patients, but could possibly be improved by modifying the criterion of presumed or probable OS.


Asunto(s)
Técnicas de Diagnóstico Oftalmológico/normas , Oftalmopatías/diagnóstico , Sarcoidosis/diagnóstico , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Reacciones Falso Positivas , Femenino , Humanos , Internacionalidad , Japón , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Estudios Retrospectivos , Sensibilidad y Especificidad
20.
Vet Surg ; 49(8): 1632-1640, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-33034920

RESUMEN

OBJECTIVE: To describe the surgical reduction of luxation of the triceps brachii tendon in a dog. ANIMAL: One 2.5-year-old 2.58 kg castrated male toy poodle. STUDY DESIGN: Clinical case report. METHODS: The dog displayed intermittent, non-weight bearing lameness of the right forelimb for approximately 18 months before presenting at the veterinary medical center. Medial subluxation of the right elbow joint was detected by palpation. The Campbell test was consistent with an increased range of motion during supination. At ultrasonographic examination, medial luxation of the triceps brachii tendon was noted, whereas collateral ligaments appeared normal. No skeletal deformities were found on radiographs of the right forelimb. The luxation of the triceps brachii tendon was surgically corrected with antirotational suture, a stopper pin, medial retinaculum release, and imbrication of the lateral retinaculum. RESULTS: The right triceps brachii tendon and elbow joint were successfully reduced. Gait returned to normal by 55 days postoperatively. No implant failure or recurrence were observed 3.5 years after surgery. CONCLUSION: Surgical reduction of a luxation of the triceps brachii tendon in a dog resolved lameness and restored the range of motion of the affected elbow, leading to good long-term outcome.


Asunto(s)
Perros/lesiones , Miembro Anterior/cirugía , Luxaciones Articulares/veterinaria , Articulaciones/cirugía , Traumatismos de los Tendones/veterinaria , Animales , Perros/cirugía , Luxaciones Articulares/cirugía , Masculino , Traumatismos de los Tendones/diagnóstico , Traumatismos de los Tendones/cirugía , Tendones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...